Joint Formulary & PAD

Dipyridamole - Thromboembolism prophylaxis

You are here : Home > Formulary Search > Dipyridamole - Thromboembolism prophylaxis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Modified release capsules
  • Oral suspension
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Dipyridamole
Indication :
Thromboembolism prophylaxis
Group Name :
Keywords :
prosthetic heart valves, prevention of thromboembolism associated with prosthetic heart valves
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

04 Sep 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Dipyridamole is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Thromboembolism prophylaxis.

  • No records returned.